Indeterminate Acute Liver Failure in a 4-Year-Old: Transfer, Workup, and Whether to List Tonight
A previously healthy 4-year-old girl is admitted with 3 days of vomiting, lethargy, and jaundice. She received acetaminophen at a total dose of 45 mg/kg over 24 hours two days ago, and her acetaminophen level is below the limit of detection. She is drowsy but arousable and answers simple questions slowly (grade II encephalopathy). Temperature 36.8 °C, heart rate 128, blood pressure 92/54, weight 16 kg. Total bilirubin 11.2 mg/dL, ALT 3,240 U/L, AST 4,110 U/L, INR 2.8 uncorrected, fibrinogen 90 mg/dL, ammonia 148 µmol/L, glucose 52 mg/dL, lactate 3.9 mmol/L, creatinine 0.6 mg/dL, platelets 112,000/µL. There is no rash, fever, or known toxin exposure. There is no family history of liver disease, and the family speaks limited English. The ICU team asks whether she needs transfer to a transplant center tonight.
1. What is your immediate management, and would you transfer her tonight?
Read the worked answer
Yes: transfer tonight to a pediatric transplant center. Grade II encephalopathy, INR 2.8, hypoglycemia, and rising ammonia define a child at high risk of death without transplant, and the etiology is unknown.
Immediate measures:
- N-acetylcysteine even though the acetaminophen level is undetectable: 150 mg/kg/day as a continuous infusion is the usual non-acetaminophen pediatric acute liver failure regimen. Start it before transfer.
- Dextrose 10% in quarter-normal saline at 1.5 times maintenance; check glucose hourly. Treat hypoglycemia aggressively.
- Correct hypophosphatemia, which is common in acute liver failure and predisposes to respiratory failure.
- Ammonia: avoid protein restriction, use lactulose for encephalopathy, and consider continuous renal replacement therapy if ammonia exceeds about 150 µmol/L and is rising, or if there is fluid overload.
- Head of bed at 30 degrees, minimal handling, no sedatives, and treat seizures. Target sodium 145–155 mmol/L with hypertonic saline if there is concern for cerebral edema.
- Do not give FFP simply to correct the INR: the INR is a prognostic marker, and FFP causes volume overload. Give it only for active bleeding or before an invasive procedure. Give vitamin K.
- Blood cultures and broad-spectrum antibiotics if there is any suspicion of sepsis; the child can deteriorate quickly.
Arrange the transfer with a physician-to-physician call and send the records and labs with the child.
2. Which etiologic tests actually change management in the first 24 hours?
Read the worked answer
Focus on diseases where the result changes what you do tonight:
- Autoimmune hepatitis: ANA, anti-smooth muscle antibody, anti-LKM1, total IgG. If positive and there is no contraindication, a steroid trial at 2 mg/kg/day with reassessment at 48–72 hours can occasionally avert transplant. Do not let the trial delay listing if the INR or encephalopathy worsens.
- Hemophagocytic lymphohistiocytosis: ferritin, triglycerides, fibrinogen, soluble IL-2 receptor, and bone marrow examination. Uncontrolled HLH is a contraindication to transplant; treatment must start first.
- Wilson disease: ceruloplasmin, 24-hour urine copper, and slit-lamp examination. Coombs-negative hemolysis with a low alkaline phosphatase relative to bilirubin suggests it. Transplant is often urgently needed.
- Mitochondrial disease: lactate and pyruvate, family history, and muscle biopsy. Some mitochondrial disorders, such as Alpers disease or valproate hepatotoxicity, recur in the graft and are contraindications to transplant.
- Infection and metabolic screens: HSV PCR, EBV, CMV, adenovirus, urine organic acids and succinylacetone, acylcarnitine profile, and alpha-1 antitrypsin phenotype.
Indeterminate pediatric acute liver failure accounts for 30–50% of cases. An early biopsy can distinguish severe hepatitis from necrosis, but it should not delay listing when the child is unstable.
3. Should she be listed tonight, and what determines that decision?
Read the worked answer
Yes - list her while continuing medical therapy. Early listing preserves the option; delisting is possible if she improves.
Poor prognostic features in pediatric acute liver failure:
- INR above 2.5 together with encephalopathy; factor V below 20–25% where available.
- Ammonia above 150–200 µmol/L, especially if rising despite treatment or requiring CRRT.
- Worsening encephalopathy, need for ventilation, hypoglycemia, and a rapidly rising bilirubin.
- Etiology matters: acetaminophen and hepatitis A have better spontaneous survival; indeterminate and Wilson disease have worse.
Contraindications to check before listing:
- Uncontrolled sepsis or shock.
- Irreversible hypoxic-ischemic brain injury.
- Extrahepatic malignancy.
- Multisystem mitochondrial disease.
- Uncontrolled HLH.
Practical points:
- In the United States, acute liver failure in a child in the ICU meets status 1A criteria; make sure the documentation matches the policy definition.
- Start living-donor evaluation in parallel; a direct living donor may be available long before a deceased-donor offer, and this child's blood type O and CMV-negative status further narrow the donor pool.
- Use an interpreter for every consent conversation, and document that the family understands that transplant may be futile if brain injury progresses.